⌕
Sanofi · SNY · Nasdaq
Tenet 34 · Weak
Compare
$48.39+0.04%At closeTenet 34 · Weak
$48.39+0.02 (+0.04%)
At close: Nov 16, 2026, 4:00 PM ET· Nasdaq · USD
$48.37−0.02 (−0.04%)
After hours: Nov 16, 2026, 6:06 PM ET

Sanofi (SNY) Key Ratios

Valuation, quality, health and growth. Every ratio ranked against its sector peers — the number we score — with its own ten-year record shown beside it for context.

Sources Company filings and market prices Filings and pricesRatios computed How we compute thisNot investment advice

42 figures withheld by our checks. Each blank figure names its reason.

—
VALUE
No data
no inputs scored
57
QUALITY
Decent
mid-pack profitability
29
HEALTH
Fragile
leverage needs watching
16
GROWTH
FCF only
growth rates not measurable; scored on FCF margin alone

A decent business at a no data price: quality 57, health 29, growth 16, each a percentile within Healthcare.

track = where peers land, worse → better (direction-adjusted: right always means better)▏sector median● you are here▲ where today's value sits in the company's own 10-year record (context, not scored)hover any metric for its formula
no inputs scored
Earnings yield (EBIT/EV)EBIT (operating income) for the latest fiscal year ÷ enterprise value on the current market cap (Greenblatt). The vendor's own earnings yield is net income to common ÷ market cap, a different figure.—Withheld by our checks.
P/E—Withheld: the market value on file does not match the share count and the price.
P/B—Withheld by our checks.
P/FCF—Withheld by our checks.
EV / EBITDA—Withheld by our checks.
29th pctileleverage needs watching
Current ratio1.088th pctile
Quick ratio(Cash, short-term investments and receivables) ÷ current liabilities, as the data vendor builds it. Its receivables include non-trade receivables, which Tenet's balance sheet shows inside other current assets.0.574th pctile
Net debt / EBITDATotal debt less cash and short-term investments, over EBITDA (operating income plus depreciation and amortisation) from the filed statements. Long-term investments are not counted as cash. For some companies they include marketable securities held for more than a year.0.9×51st pctile
Interest coverage—Not measured: there is no interest expense on file.
Debt / equity0.2850th pctile
57th pctilemid-pack profitability
ROIC6%61st pctile
ROE11%66th pctile
Gross margin—Withheld by our checks.
Net margin16.8%80th pctile
Income quality (CFO/NI)1.16×22nd pctile
Piotroski F—Withheld by our checks.
Altman Z—Withheld by our checks.
16th pctilegrowth rates not measurable; scored on FCF margin alone
Revenue CAGRThe yearly rate that compounds the earliest fiscal year's revenue into the latest one, over the true number of fiscal years between them (up to five). When the earliest year's revenue is zero or negative, the rate starts from the first later year with at least $10M of revenue, provided at least three years remain.—This growth figure starts in a period outside the history your plan includes.
EPS CAGR—This growth figure starts in a period outside the history your plan includes.
FCF margin—Not reported in the company's filings for this period.
the receipts behind the numbers above
Greenblatt earnings yield—EBIT ÷ EV The vendor's "earningsYield" is NI ÷ market cap, which is not Greenblatt's formula.
ROIC6%NOPAT ÷ invested capital The vendor's simple ROIC, not its tiny-base roic tag; withheld when a negative EBIT flips its sign.
Interest coverage— Guarded, not faked: we have no interest-expense figure on file for this company, so it's excluded from the ranking instead of rendered as garbage.
Percentiles computed nightly against 313 Healthcare peers from our ingested fundamentals DB · raw statements for corrected metrics. Direction-adjusted: for "lower is better" ratios (P/E, D/E…) the percentile is flipped so right always means better. The percentile is the stock's rank among sector peers, the number that is scored. The triangle marks where the current value sits in the company's own ten-year annual record, shown for context and never blended into the score. Computed Nov 13, 2026 · Not investment advice.

Install Tenet on your phone

Tenet home pageMethodology© 2026 Tenet Investing Inc.

Data from Intrinio and Financial Modeling Prep.